Analytical Data
-
基因名
FABP9
- Application
-
别名
FABP9MRG;Fatty acid-binding Protein 9
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q0Z7S8
-
表达区间
1-132aa
-
氨基酸序列
MGSSHHHHHHSSGLVPRGSHMGSHMVEPFLGTWKLVSSENFEDYMKELGV NFAARNMAGLVKPTVTISVDGKMMTIRTESSFQDTKISFKLGEEFDETTA DNRKVKSTITLENGSMIHVQKWLGKETTIKRKIVDEKMVVECKMNNIVST RIYEKV
-
分子量
18 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FABP9, or Fatty Acid-Binding Protein 9, is a member of the FABP family, known for its role in the intracellular transport of long-chain fatty acids and other lipid molecules. Research into FABP9 is particularly relevant due to its association with various metabolic processes and diseases, including obesity, diabetes, and cardiovascular disorders. Recent studies have highlighted FABP9’s involvement in regulating inflammation and immune responses, suggesting its potential as a biomarker for metabolic conditions and a target for therapeutic interventions. The recombinant production of FABP9 allows for detailed structural and functional analyses, enabling scientists to elucidate its mechanisms of action and interaction with fatty acids. This foundational knowledge is crucial for understanding its physiological significance and developing strategies to manipulate its pathways for disease prevention and treatment. Additionally, given the increasing prevalence of metabolic diseases worldwide, exploring and harnessing the properties of FABP9 through recombinant technology could open new avenues for innovative therapies aimed at managing these conditions more effectively.
